Bank of America
BIOA

Bank of America’s BioAge Labs BIOA Stock Holding History

Bank of America’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Sell
61,508
-127,175
-67% -$2.45M ﹤0.01% 4486
2025
Q4 		$2.5M Buy
188,683
+177,564
+1,597% +$1.57M ﹤0.01% 3897
2025
Q3 		$65.4K Buy
11,119
+3,517
+46% +$16.5K ﹤0.01% 6765
2025
Q2 		$31.4K Buy
7,602
+1,476
+24% +$5.95K ﹤0.01% 6943
2025
Q1 		$23K Sell
6,126
-13,693
-69% -$63.3K ﹤0.01% 6936
2024
Q4 		$115K Buy
19,819
+19,294
+3,675% +$333K ﹤0.01% 6338
2024
Q3 		$10.9K Buy
+525
New +$10.5K ﹤0.01% 6876

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Bank of America's BIOA Position: Q1 2026 in Review

Bank of America reduced its BioAge Labs (BIOA) stake by 67% in Q1 2026, selling an estimated $2.45M and leaving 61,508 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4486.

Bank of America first reported a position in BIOA in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.5M in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Bank of America held 61,508 shares of BioAge Labs worth $1.08M as of Q1 2026.
  • Bank of America sold 127,175 BioAge Labs shares in Q1 2026, an estimated $2.45M.
  • BioAge Labs made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4486 holding.
  • Bank of America first reported a position in BioAge Labs in Q3 2024 and has held it in 7 quarters since.
  • Bank of America's BioAge Labs position peaked at $2.5M in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.